Budesonide inhalation - Vectura
Alternative Names: AKITA inhaled budesonide suspension - Vectura; Favolir; Flavorestin™; Scipe; VR 475; VR 647Latest Information Update: 19 Dec 2021
At a glance
- Originator Activaero GmbH
- Developer Vectura
- Class Alcohols; Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Dioxoles; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Asthma
- No development reported Cough; Wheezing
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for phase-I development in Asthma(In adults) in USA (Inhalation, Aerosol)
- 28 Sep 2021 No recent reports of development identified for phase-I development in Cough(In children, In infants) in USA (Inhalation, Aerosol)
- 28 Sep 2021 No recent reports of development identified for phase-I development in Wheezing(In children, In infants) in USA (Inhalation, Aerosol)